Leading Amlodipine Besylate Companies in Qatar | Players 2026

Code: MTA13213 Publication Date: Jul 2026

Leading Amlodipine Besylate Companies in Qatar

The following is a data-backed list of the leading Qatar Amlodipine Besylate companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the Qatar Amlodipine Besylate Industry, including Pfizer Inc., Novartis AG, and other established names.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Qatar Amlodipine Besylate Industry.

List of Amlodipine Besylate companies in Qatar:

1. Pfizer Inc.

Company NamePfizer Inc.
Established Year1849
HeadquartersNew York, USA
Official WebsiteClick Here

As the original innovator of the molecule, Pfizer maintains a premium position by providing extensive clinical data and reliable, high-purity formulations for long-term hypertensive management.

2. Novartis AG

Company NameNovartis AG
Established Year1996
HeadquartersBasel, Switzerland
Official WebsiteClick Here

A leader in global medicine, Novartis focuses on high-precision quality control and advanced therapeutic combinations, ensuring consistent efficacy for cardiac patients.

3. Viatris Inc.

Company NameViatris Inc.
Established Year2020
HeadquartersCanonsburg, USA
Official WebsiteClick Here

Dedicated to expanding access, Viatris delivers scalable and affordable cardiovascular medicines that support the large-scale public health initiatives across the Qatari landscape.

4. Sun Pharmaceutical Industries Limited

Company NameSun Pharmaceutical Industries Limited
Established Year1983
HeadquartersMumbai, India
Official WebsiteClick Here

A dominant force in the global generic segment, Sun Pharma provides cost-effective, high-quality Amlodipine solutions that drive broad-spectrum accessibility for diverse patient groups.

5. Cipla Limited

Company NameCipla Limited
Established Year1935
HeadquartersMumbai, India
Official WebsiteClick Here

Leveraging decades of expertise, Cipla focuses on rapid distribution and reliable medication availability, tailoring its supply chain to meet the specific needs of the Qatari market.

6. Teva Pharmaceutical Industries Limited

Company NameTeva Pharmaceutical Industries Limited
Established Year1901
HeadquartersTel Aviv, Israel
Official WebsiteClick Here

As one of the world's largest generic providers, Teva emphasizes volume, reliability, and global compliance standards to support large-scale cardiovascular disease mitigation.

7. Glenmark Pharmaceuticals Limited

Company NameGlenmark Pharmaceuticals Limited
Established Year1977
HeadquartersMumbai, India
Official WebsiteClick Here

Specializes in dermatology and cardiovascular segments, Glenmark provides highly stable formulations that remain effective under various environmental storage conditions.

8. Hikma Pharmaceuticals PLC

Company NameHikma Pharmaceuticals PLC
Established Year1978
HeadquartersLondon, UK
Official WebsiteClick Here

Deeply integrated into the Middle East market, Hikma excels in localized distribution and regulatory agility, ensuring consistent supply of essential heart health medication.

9. Lupin Limited

Company NameLupin Limited
Established Year1968
HeadquartersMumbai, India
Official WebsiteClick Here

A research-oriented firm that emphasizes the bioavailability of its Amlodipine Besylate tablets, ensuring high therapeutic success rates in chronic care environments.

10. Sandoz Group AG

Company NameSandoz Group AG
Established Year1886
HeadquartersBasel, Switzerland
Official WebsiteClick Here

A global leader in generic and biosimilar medicine, Sandoz provides high-volume, reliable cardiovascular drugs that balance cost with international quality benchmarks.

11. Aurobindo Pharma Limited

Company NameAurobindo Pharma Limited
Established Year1986
HeadquartersHyderabad, India
Official WebsiteClick Here

Supports the healthcare ecosystem through a highly verticalized supply chain, allowing for optimized production and delivery of essential antihypertensives.

Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All